IQVIA™ Pharma Deals: Review and Analysis

IQVIA Pharma Deals Review

ISSN 1756-7874. The business journal providing incisive analysis and expert opinion on the major deals.

Pharma Deals Review Latest Articles

Vertex Buys Alpine Immune Sciences and its Kidney Disease Drug for US$4.9 B Published: 17 Apr-2024
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2024 Issue: 4
Genmab Acquires ADC Drug Developer ProfoundBio for US$1.8 B Published: 5 Apr-2024
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2024 Issue: 4
IQVIA Pharma Deals Review of 2023 Published: 28 Mar-2024
By: Lucy Haggerty, Ayush Saxena & Taskin Ahmed
Abstract Fulltext:
Volume: 2024 Issue: 3
Boehringer Ingelheim Collaborates with Sosei Heptares for Antipsychotic Drugs Published: 27 Mar-2024
By: Amit Kaushik
Abstract Fulltext:
Volume: 2024 Issue: 3
AstraZeneca Buys Fusion Pharmaceuticals for US$2 B Published: 22 Mar-2024
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2024 Issue: 3

You can click on any of the bars to open a new page with the corresponding deals.

Login Problems

Please enter your username or email address and we will email you your login details.

Latest Article

Vertex Buys Alpine Immune Sciences and its Kidney Disease Drug for US$4.9 B

Published: 17 Apr-2024
By: Lucy Haggerty Abstract Fulltext:

DEAL REVIEW OF 2023

Click Here to Access the Article

IQVIA™ Pharma Deals: Review and Analysis